BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,709,000 | -10.5% | 10,000,000 | -9.1% | 0.63% | +21.3% |
| Q2 2023 | $10,848,475 | -9.7% | 11,000,000 | -6.0% | 0.52% | +40.7% |
| Q1 2023 | $12,018,591 | +25.6% | 11,700,000 | +30.0% | 0.37% | +23.7% |
| Q4 2022 | $9,569,790 | +17.2% | 9,000,000 | +9.8% | 0.30% | +9.5% |
| Q3 2022 | $8,163,000 | +0.2% | 8,200,000 | 0.0% | 0.27% | +7.5% |
| Q2 2022 | $8,143,000 | +7.8% | 8,200,000 | +9.3% | 0.26% | +21.4% |
| Q1 2022 | $7,552,000 | – | 7,500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |